The drug is: Niacin, or nicotinic acid (vitamin B3, ou PP) (do not confuse with nicotine)
Nicotinic acid, or niacin, is known for its normolipidemic properties since the 1950s. It was the subject of the first trial of cardiovascular prevention by intervention on the lipidic factor, the coronary drug project (CDP). Despite significant side effects, mainly flushing, it has since been used, mainly in the United States, as a treatment for mixed hyperlipidemias, thanks to its hypotriglyceridemic effect for the increase of HDL-cholesterol.